Updated safety and clinical activity results from a phase Ib study of atezolizumab + bevacizumab in hepatocellular carcinoma (HCC)
Journal
-
- Annals of Oncology
-
Annals of Oncology 29 viii718-viii719, 2018-10
Elsevier BV
- Tweet
Details 詳細情報について
-
- CRID
- 1364233268525448448
-
- ISSN
- 09237534
-
- Data Source
-
- Crossref